Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of DA-3002 [Phase 3]

View source ↗

Summary

Phase 3 trial of DA-3002 for Turner's syndrome has completed; the update does not provide efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• DA-3002

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Turner's Syndrome | Phase 3 | Status: COMPLETED